CN114796434A - Pill for keeping healthy qi and pathogenic factors dry - Google Patents
Pill for keeping healthy qi and pathogenic factors dry Download PDFInfo
- Publication number
- CN114796434A CN114796434A CN202210491479.8A CN202210491479A CN114796434A CN 114796434 A CN114796434 A CN 114796434A CN 202210491479 A CN202210491479 A CN 202210491479A CN 114796434 A CN114796434 A CN 114796434A
- Authority
- CN
- China
- Prior art keywords
- radix
- aconiti lateralis
- pill
- rhizoma atractylodis
- radix aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 22
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 41
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 9
- 241000202726 Bupleurum Species 0.000 claims abstract description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 241000208340 Araliaceae Species 0.000 claims abstract description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 3
- 241000227129 Aconitum Species 0.000 claims description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 10
- 235000008397 ginger Nutrition 0.000 claims description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 6
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 6
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 241000132012 Atractylodes Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 235000008429 bread Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 238000004898 kneading Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000447 pesticide residue Substances 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 208000002193 Pain Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 241000282414 Homo sapiens Species 0.000 abstract description 3
- 235000001188 Peltandra virginica Nutrition 0.000 abstract description 2
- 239000003651 drinking water Substances 0.000 abstract description 2
- 235000020188 drinking water Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 17
- 210000002216 heart Anatomy 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 9
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 9
- 229940039750 aconitine Drugs 0.000 description 9
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 229940126680 traditional chinese medicines Drugs 0.000 description 7
- 240000004371 Panax ginseng Species 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 241000976983 Anoxia Species 0.000 description 3
- 241000132011 Atractylodes lancea Species 0.000 description 3
- 241000675108 Citrus tangerina Species 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000004347 Perilla Nutrition 0.000 description 3
- 244000124853 Perilla frutescens Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000007953 anoxia Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- -1 demethyl linderane Chemical compound 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 206010061876 Obstruction Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940023019 aconite Drugs 0.000 description 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- GQRPJUIKGLHLLN-VSTHTWNCSA-N mesaconine Chemical compound COC[C@]12CN(C)C3[C@@H]4[C@H](OC)[C@H]1[C@]3([C@@H]1C[C@@]3(O)[C@H](O)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]3OC)[C@H](C[C@H]2O)OC GQRPJUIKGLHLLN-VSTHTWNCSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000037321 sleepiness Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000000439 tumor marker Substances 0.000 description 2
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
- LVIDDMJSLAVTSZ-UHFFFAOYSA-N 2,5-dimethyl-8-propan-2-yl-1,2,3,4-tetrahydronaphthalene Chemical compound C1CC(C)CC2=C1C(C)=CC=C2C(C)C LVIDDMJSLAVTSZ-UHFFFAOYSA-N 0.000 description 1
- JZRBSTONIYRNRI-UHFFFAOYSA-N 2-azaniumyl-3-(3-methylphenyl)propanoate Chemical compound CC1=CC=CC(CC(N)C(O)=O)=C1 JZRBSTONIYRNRI-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000254137 Cicadidae Species 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 235000003913 Coccoloba uvifera Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 244000050907 Hedychium coronarium Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- KBMSVODXFLAQNJ-ZEBDJQDSSA-N Linderane Natural products O=C1O[C@@H]2[C@@H]3O[C@]13CC/C=C(/C)\Cc1occ(C)c21 KBMSVODXFLAQNJ-ZEBDJQDSSA-N 0.000 description 1
- 240000002262 Litsea cubeba Species 0.000 description 1
- 235000012854 Litsea cubeba Nutrition 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- 241000379547 Trifolium medium Species 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- MORATRGJOYWSOZ-UHFFFAOYSA-N acetaldehyde;naphthalene Chemical compound CC=O.C1=CC=CC2=CC=CC=C21 MORATRGJOYWSOZ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229930006737 car-3-ene Natural products 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229930007796 carene Natural products 0.000 description 1
- BQOFWKZOCNGFEC-UHFFFAOYSA-N carene Chemical compound C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- PHASMOUKYDUAOZ-IXLJIIPOSA-N deoxyaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6(COC)CN(C5[C@H]([C@H](OC)[C@H]64)[C@](OC(C)=O)([C@H]31)[C@@H](O)[C@@H]2OC)CC)C(=O)C1=CC=CC=C1 PHASMOUKYDUAOZ-IXLJIIPOSA-N 0.000 description 1
- PHASMOUKYDUAOZ-UHFFFAOYSA-N deoxyaconitine Natural products C12C(OC(C)=O)(C(O)C3OC)C(C(OC)C45)C6N(CC)CC4(COC)CCC(OC)C56C2CC3(O)C1OC(=O)C1=CC=CC=C1 PHASMOUKYDUAOZ-UHFFFAOYSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000013526 red clover Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- PGTJIOWQJWHTJJ-UHFFFAOYSA-N trans-Calamenene Natural products C1=C(C)C=C2C(C(C)C)CCC(C)C2=C1 PGTJIOWQJWHTJJ-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a pill for preventing internal healthy qi from drying. The pill for preventing internal healthy qi and pathogenic factors from being dried consists of the following components: radix Glycyrrhizae Preparata (radix Glycyrrhizae Preparata) two, rhizoma Zingiberis (rhizoma Zingiberis recens) two halves, and radix Aconiti lateralis Preparata (radix Aconiti lateralis Preparata) 45g or two, radix Ginseng Rubra (radix Ginseng Rubra) two, radix bupleuri (radix bupleuri) two, ramulus Cinnamomi (ramulus Cinnamomi) two, Poria (Poria cocos) two, and rhizoma Atractylodis (rhizoma Atractylodis) two halves; the radix Aconiti lateralis is salted radix Aconiti lateralis. The invention is based on the 'Sirentang' to compound red ginseng, cassia twig, bupleurum, tuckahoe and rhizoma atractylodis with proper dosage, mainly treats diseases such as cold limbs and various yang deficiency, enhances the immunity of human body, and causes little or no illness. Belongs to the ancient and modern use in the field of disease prevention and treatment of Chinese traditional medicine, saves limited resources, is green and environment-friendly, is convenient to carry, is convenient and quick to take, can be taken by drinking water, does not need complicated decoction, has reliable curative effect, and relieves repeated external infection and long-term pain, so that a patient can recover early and the body resistance is enhanced.
Description
The application is a divisional application with the application date of 2017, 05 and 25, the application number of 201710412581.3 and the invention name of 'pill for preventing internal healthy qi from drying out'.
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a pill for preventing internal healthy qi from drying.
Background
The formula is published in Shang Han Lun (treatise on febrile diseases) of the classic book of traditional Chinese medicine in China, which is published by Beijing 2006.10 by the Chinese traditional medicine publishing company, Tairui printing Limited company in Beijing, Zhongjing in the Han Dynasty, Yangjinping and the like. Book 138, 152, 164 (decoction of four adverse qi) ─ Si Yi Tang (decoction of four adverse qi).
In the clinical verification and application of more than 50 years, red ginseng, cassia twig, radix bupleuri, poria cocos and rhizoma atractylodis are added on the basis of 'sini decoction', all yang-strengthening and yang-weakening medical cases in clinical departments certainly belong to miraculous effects, and the thought motivation of the inventor is based on the idea that homeopathic patients and traditional Chinese medicine are greatly developed to benefit human beings, and books of the formula are background technologies. The traditional Chinese medicine composition inherits the successful experience of predecessors, draws the successful experience in clinical treatment, stands at the height of history, captures the modern scientific theory and result, analyzes and abstracts each traditional Chinese medicine, and carries out error teaching and training, adds and subtracts the theory and effect system to smoothly move forward along a scientific orbit, so that a patient in the sky is recovered early and is prolonged in life.
Disclosure of Invention
Pill for keeping healthy qi and pathogenic factors dry
Firstly, a square source: the book Shang Han Lun (treatise on exogenous febrile disease) is published by China traditional Chinese medicine publication Hebeijing in 2006 in 10 months.
II, medicine composition: in the decoction for treating the diseases of the four adverse qi (two honey-fried licorice roots, two halves of dried ginger and one monkshood, the conversion is 45g, and one or two in east Han is equal to 15.625g according to the current metric system, one or two in east Han) are added two red ginseng, two cassia twig, two radix bupleuri, two poria cocos and two rhizoma atractylodis.
Thirdly, efficacy: revive yang and rescue collapse, strengthen the body resistance and eliminate pathogenic factors.
Fourthly, mainly treating: frequently and repeatedly treating cold (common cold), cold running and snivel when meeting cold, long-term cold hands, feet and vests, stomach and intestine and abdominal pain which are favored to warm and press, pain and pain reduction due to near heat, stomach pain and acid regurgitation, cold cough, asthma, white greasy tongue fur, white phlegm which is white bubble phlegm, pain of bone joints, numbness of extremities, edema of lower limbs, difficult tolerance of dysmenorrhea, pale complexion, cold headache, blood cold, coronary heart pain caused by poor blood flow, various chronic hepatitis (the traditional Chinese medicine belongs to yellow yin), various yang and body resistance failure and the like.
Fifthly, contraindications: during taking, all antibiotic western medicines for diminishing inflammation, all traditional Chinese medicines for clearing heat and annealing and finished Chinese medicinal products are forbidden to eat aquatic food.
Sixthly, pharmacological research:
1. honey and sweet honey-fried licorice root (synonym) American grass, Guaolao and meadow clover
A base source: is root and rhizome of Glycyrrhiza uralensis Fisch, Glycyrrhiza glabra L, and Glycyrrhiza inflata L of Glycyrrhiza of Leguminosae. The second edition of the Chinese medicine dictionary (hereinafter referred to as the Chinese pharmacopoeia) on page 788 was printed at 2005.12 Shanghai science and technology Press 2012.12.19 times.
Pharmacology: antimicrobial effect, in vitro inhibition of licorice leachate by bacillus, staphylococcus aureus, pseudomonas aeruginosa, streptococcus B, etc.; the preparation has adrenocortical hormone-like effect, and the Glycyrrhrizae radix preparation has adrenocortical hormone effect. Glycyrrhizic acid and glycyrrhetinic acid, which are main active ingredients, can possibly inhibit the beta-hydroxysteroid dehydrogenase of the kidney to take effect.
The medicine property is as follows: sweet and neutral in nature, they enter spleen, stomach, heart and lung meridians.
The functional indications are as follows: harmonizing the middle energizer and relieving urgency, moistening lung, removing toxicity, and harmonizing all the herbs, stir-baked for treating weakness of spleen and stomach, lassitude and poor appetite, abdominal pain and loose stool, limb spasm and acute pain, palpitation, dry heart, consumptive lung disease and cough, unprocessed for treating sore throat, sore and carbuncle, pyogenic infections of infants, and food poisoning by drugs.
2. Ginseng:
a base source: is root of Panax ginseng C.A.Meyer belonging to Araliaceae.
Pharmacology: synonyms, herba cistanches, ghost covers, yellow ginseng and jade ginseng.
Medicine property: sweet, slightly bitter and warm. It enters lung, spleen, heart and kidney meridians.
The functional indications are as follows: tonify primordial qi, secure collapse, promote fluid production, induce tranquilization. It is mainly used for treating qi deficiency and fluid impairment, fatigue and asthenia, lassitude, anorexia, emesis, constipation, short breath, spontaneous perspiration, chronic cough, asthenic asthma, diabetes, insomnia, palpitation, amnesia, sexual impotence, frequent micturition, metrorrhagia, etc., as detailed in pages 42-45 of the pharmacopoeia.
3. Dried ginger: synonyms, white ginger, junn ginger.
A base source: is dried rhizome of plant of Zingiberaceae.
The components: the dried ginger oil contains volatile components, alpha-shogaol and the like.
Pharmacology: tranquilizing, analgesic, antiinflammatory, cardiovascular, anticoagulant, adrenal cortex, digestive system, and anoxia resisting effects.
Medicine property: it enters spleen, stomach, heart and lung meridians.
The functional indications are as follows: the pharmacopoeia and the predecessor are not found that the ginger and the dried ginger can relieve the drug poisoning of Ranunculaceae (aconite) and Araceae, and the frequent trial and error of the inventor makes the poisoned person turn to Yiyi pharmacopoeia on 98-101 pages.
4. Radix Aconiti lateralis
A base source: the lateral root (seed root) (original plant) of Aconitum carmichaeli Debx (cultured product) of Ranunculaceae and Aconitum is referred to as "Aconitum chuanxiong (Chuanwu)" strip.
The components: the monkshood contains alkaloids: aconitine, mesaconine, hypaconitine, talaconine and uramine, isodelphinine, deoxyaconitine, uracil, mesaconine, etc.
Pharmacology: effects on the cardiovascular system; the cardiotonic component of radix Aconiti lateralis mainly comprises racemic demethyl linderane, clavine chloride, norsalsoline, etc.; anti-myocardial ischemia and anti-hypoxia effects; an anti-shock effect; anti-inflammatory effects; has antitumor effect.
Medicine property: pungent, sweet, hot and toxic. It enters heart, kidney and spleen meridians.
The functional indications are as follows: reviving yang and rescuing from collapse, dispelling cold and removing dampness. It is mainly used for treating excessive yin repelling yang, excessive sweat and yang death, vomiting and diarrhea syncope, cold pain in heart and abdomen, cold dysentery, beriberi edema, wind-cold-dampness spleen, yin jaundice sore and leakage and all the diseases of cold sinking and cold fixing … …
Contraindications are as follows: yin deficiency and yang excess, true heat with false cold, and contraindicated for pregnant women, it is not advisable to use white spirit as a guide. Improper use of this herb can cause poisoning! Refer to the book 1670-1674 of the monk shood headings in pharmacopoeia.
5. Bupleurum root: famous people, peruvian rose root, mountain vegetable and firewood.
A base source: is root of Bupleurum scorzonerifolium or Bupleurum diphyllum of Bupleurum of Umbelliferae.
Original plants: 1. bupleurum root, Bupleurum scorzonerifolium (northeast), Bupleurum scorzonerifolium (Shandong) belongs to perennial herb and includes Bupleurum nankinense and Bupleurum scorzonerifolium.
The components: the radix bupleuri contains volatile oil, o-methoxyphenol, heptalactone, sebaceous lactone, eugenol, and alkanoic lactone cresol.
Pharmacology: anti-inflammatory, anti-cns effects; has antipyretic effect and can lower body temperature.
The functional indications are as follows: the effect of the medicine is similar to that of codeine phosphate 7.6 mg/kg; the vinegar-fried radix bupleuri and vinegar-mixed radix bupleuri can obviously reduce carbon tetrachloride and serum alanine Aminotransferase (ALT) of a poisoned mouse and have the effect of slightly relieving liver injury; acting on gastrointestinal tract, saikosaponin can excite isolated smooth intestinal muscle, and is not resisted by atropine; influence on immune function and blood lipid, and increase concanavalin. 5. Antibacterial and antiviral effects; bupleurum root from the Wen Zhong xi Lu is slightly bitter in flavor, neutral in nature, and capable of generating hair qi due to congenital shaoyang, and is a main drug of the shaoyang, and can be used for treating both cases of shaoyin, uncomfortable liver qi, and excessive gallbladder fire, which can dissipate the pathogenic wind; the term "Shen nong Ben Cao Jing" means that the pathogenic factors are mainly cold and heat, and the pathogenic factors are also qi stagnation in the stomach and intestine and diet accumulation, but the theory of five elements, wood can dredge soil, radix bupleuri prefers to achieve the wood qi of Shaoyang, so the qi of Shaoyang can dredge the depression of stomach qi, and the qi stagnation diet accumulation can be digested automatically. Pages 2569 to 2574 of the book < pharmacopoeia >.
6. Ramulus Cinnamomi, synonym willow osmanthus (Shennong herbal)
A base source: is the twig of Cinnamomum cassia Presl of Lauraceae. See the "cinnamon" strips for (original plants).
The components: comprises volatile oil, cinnamaldehyde, benzyl levulinate, cinnamyl acetate, calamene, coumarin, etc. … ….
Pharmacology: antibacterial and antiviral effects; sedative and anticonvulsant effects; anti-inflammatory effects; has effect on blood of blood vessel.
Medicine property: pungent, sweet and warm. It enters bladder, heart and lung meridians.
The functional indications are as follows: dispel cold, release exterior syndrome, warm meridians and tonify yang. Mainly used for treating wind-cold exterior syndrome, cold-warm pain type arthralgia, cold limbs, amenorrhea, dysmenorrhea, obstruction in the abdomen, chest arthralgia, palpitation, phlegm and fluid retention, dysuria; pages 2521 to 2524 are registered in the pharmacopoeia.
7. Tuckahoe, poria cocos: the food is prepared from the heterogenic Fuzhuan food, the non-flour food, the yam tuber and the pine mushroom and cassava.
A base source: is sclerotium of Poria cocos (Schw.) wolf of Polyporaceae of Aphyllum.
The components: the sclerotium contains various components, triterpenes: pachymic acid, hydroxyl odontic acid, methyl ester of Poria acid, etc.
Pharmacology: diuretic action A25% poria cocos ethanol infusion was injected into the abdominal cavity of a normal rabbit at a dose of 0.5g/kg, resulting in diuretic action. (ii) a Influence on digestive system function, and prevention of gastric ulcer; liver damage; anti-cancer effect; immunity enhancing effect, etc.
Medicine property: sweet, bland and neutral, enter heart, spleen, lung and kidney meridians.
The main treatment functions are as follows: diuresis inducing and dampness eliminating, spleen invigorating and stomach regulating, heart calming and mind tranquilizing, diarrhea, palpitation insomnia, amnesia, nocturnal emission and whitish and turbid urine. Pharmacopoeia, supra, at pages 2152-2155.
8. Rhizoma atractylodis: (herbal derived sense) synonyms: mountain essence, Xian Zhu
A base source: is rhizome of Atractylodes lancea, Atractylodes japonica, and Atractylodes japonica of Compositae.
The components: the Litsea cubeba rhizome contains volatile oil; carene (2-cayene) 1.3.4.5.6.7-hexahydro-2.5.5-trimethyl-2H-2, 4 alpha-ethanone naphthalene, isopropanol glucoside and the like.
Pharmacology: has effects in regulating gastrointestinal function, and can be used for treating digestive system diseases, gastritis, and gastric ulcer; the influence on the liver can obviously promote the synthesis of liver protein, and the rhizoma atractylodis and the contained atractylol and atractylone thereof have obvious protective effect on preventing liver cells; reducing blood sugar.
Medicine property: acting on the digestive system; gastrointestinal motility; has effects on blood sugar; anti-hypoxia effect; negative blocking of the nicotinic (N) receptor; anti-arrhythmic effect; can obviously promote the synthesis of liver protein for the liver and has obvious prevention effect on the damage of liver cells.
Medicine property: pungent, bitter and warm. It enters spleen, stomach and liver meridians.
The functional indications are as follows: dry dampness and invigorate spleen, dispel wind-damp and improve vision. Mainly treats damp sleepiness of spleen and stomach, lassitude, sleepiness, chest fullness, abdominal distension, inappetence, vomiting, diarrhea, phlegm retention, damp swelling, exterior syndrome with dampness, headache and body heaviness, arthralgia syndrome with dampness, limb joint soreness and pain aggravation, flaccidity 36484m and night blindness.
Detailed Description
The required Chinese medicinal materials are selected according to the formula strictly, the Chinese medicinal materials are not mildewed, have no impurities, are not damaged by worms, have no pesticide residues, have no heavy metal pollution and the like, and the common salt or the following raw materials are required to be added to the monkshood after the monkshood is removed: the book is printed on page 220 of the book of the world traditional medicine research of the Shang hong news publication and the medicine publishing society 1 month 1 day 1999, page 1098 of the book of the famous medical science and college diagnosis and treatment science of famous physicians and New year 5 months 2000, page 668 to 669 of the book of Yan Fu Zi, Chuan Wu and Ku Fu Zi kino three essences of liver and kidney homology of Lian Fu Zi, the book of the Shang Ting court division of China, the aconitine in Beijing and Fu Zi is extremely toxic, and the main product is the Zhongzhen town of the county oil of Sichuan river, and the second product is the Shanxi Linchuan regional world. Contains aconitine and aconitine as main components.
Pharmacology: the cardiotonic effect is used for resisting myocardial ischemia and anoxia, and the influence on blood pressure and blood vessels is used for improving the high-pressure damage of thoracic aorta intima; the aconite root has obvious effect of preventing and curing various shocks.
The aconitine content is greatly reduced after injection, and the aconitine is converted into the aconitine with extremely low toxicity.
Efficacy of aconitine: restoring yang and relieving collapse, tonifying fire and supporting yang, warming middle-jiao to alleviate pain, dispelling pathogenic wind-cold dampness, and can be used for treating yang exhaustion, collapse, cold limbs, slight pulse, fistula, cold womb, heart cold, vomiting and diarrhea due to deficiency cold, edema due to yin cold, yang deficiency, exogenous pathogenic factor, heart failure, edema, cold asthma, cold limbs, emphysema due to vest cold, cor pulmonale, myocardial ischemia, cerebral ischemia and anoxia, and dysmenorrhea due to deficiency cold. Aconitine directly excites hypothalamic CRF nerve cells, has definite curative effect on all yang deficiency (fire deficiency symptoms) in three minutes, and has the following advantages from the traditional Chinese medicine perspective: the deficiency of kidney yang, which reflects the significantly low level of urocorticosteriod, can restore normal values through warming and recuperating kidney yang, while the function of Fu Zi is not satisfactory. A book (pages 668-669) from famous Chinese physicians for diagnosis and treatment of high and new diseases.
Mixing other eight traditional Chinese medicinal materials, drying, cooling, coarse screening and crushing, repeatedly mixing, repeatedly crushing by using a fine screen, uniformly mixing with 2-3% of wheat flour paste, kneading into a material shape before bread steaming, making into pills by using a water pill machine, drying the finished products, sterilizing and drying, drying the finished products according to the required temperature of the medicaments, filling into bottles, packaging, and finally performing radiation sterilization.
1. The traditional Chinese medicine has a peculiar part, the five elements theory that five substances including wood, fire, soil, gold and water are generated, restricted and counter-restricted in the cause and effect relationship are tightly grasped for analysis, all the traditional Chinese medicines returning fire can recover yang and save energy, all the symptoms of cold limbs, cold waistcoat, white and thick tongue coating, existence of the people, no failure of qi, and returning of the heart to the adverse side without stopping and beating can be regenerated.
The pill is designed for yang deficiency and healthy qi deficiency, and for yang qi deficiency, and can be used for the old, the middle-aged, the young and the women, especially for the cases of ineffectiveness of the traditional Chinese medicines, such as antibiotics, various anti-inflammatory medicines, infusion injection, heat clearing and fire removing. From the formulation: the monkshood and the cassia twig are used for warming and nourishing fire in water, namely kidney yang, kidney water, heart fire, namely water-fire coordination (modern medicine is replaced, adrenal gland in kidney is forced to operate normally), ancient people cloud: the two operations of tonifying fire are to eliminate yin and mildew, and dried ginger and honey-fried licorice root are to radiate the bones of limbs (the limbs are the root of all yang) from Zhongzhou, so that the kidneys first and the acquired spleens are all concerned, the kidneys are the root of all the activity energy of people from the innate root, and the engine started by heart fire is an engine started by true yin and true yang on the kidneys, and water and fire cannot be supplemented (restricted) by Guifu, dried ginger and yang-supporting as tiger and winged. Radix glycyrrhizae preparata and red ginseng has the effects of strengthening the primordial qi and consolidating the constitution, ginseng, radix glycyrrhizae preparata and poria cocos are moderate, ginger and cassia twig are too violent to ensure that yin and yang are mutually rooted, cassia twig and radix bupleuri have the effects of inducing sweat and relieving muscles to communicate heart and kidney water-fire coordination, liver and kidney homology, liver blood collection, kidney essence collection, liver and kidney homology, atractylodes rhizome, rhizoma atractylodis, poria cocos, tranquilizing and allaying excitement (the mind is mastered), poria cocos, diuresis is slightly oozed, and the two technologies complement each other one above the other. The formula has wide curative effect range and can achieve the effect of the raft-drum if the human takes honey-fried licorice root for tonifying qi and protecting yin.
All the traditional Chinese medicines with the functions of eliminating dampness and promoting urination can remove dampness and toxicity, bacteria can not be hidden in the body, the environment for survival can be lost when the bacteria are removed once the bacteria are wet, chicken can be hatched at a proper temperature, the chicken cannot be hatched at a high temperature and a low temperature, the chicken cannot sprout at a proper temperature, the plant cannot sprout without proper temperature and water, and the mysterious place of the traditional Chinese medicine is known.
The virus (including epidemic disease) pointed by the traditional Chinese medicine is modern bacteria, and the epidemic is modern virus (infectious disease), namely modern infectious chronic hepatitis, chronic enteritis, chronic gastritis and the like; bacteria and viruses lose certain conditions and cannot breed and propagate under the environment, so that vital qi and internal storage and evil cannot interfere, five elements of the traditional Chinese medicine explain to be mutually balanced, correct bias and achieve yin-yang balance, and the Ming Dynasty famous physicians Zhang Jingyue have a sentence best-minded saying: although the physician has a complicated and obvious disadvantage of yin and yang, this is the absolute advantage of the traditional Chinese medicine.
Contraindications: during taking, all aquatic foods and cold foods are prohibited to eat, all anti-inflammatory western medicines such as infusion, injection and the like are stopped to take, all traditional Chinese medicines for clearing heat and removing internal heat and finished traditional Chinese medicine products are taken.
Diarrhea is caused by normal natural phenomenon without panic, and is caused by thawing, loose stool or watery diarrhea after diarrhea is normal, and the spirit is doubled after diarrhea, so people feel refreshed and refreshed.
Why should be made into water-paste pills?
1. The components of the traditional Chinese medicine which cannot be dissolved and extracted completely are protein, carbohydrate, fat and mineral substances;
2. the easily soluble and extractable components are volatile lipid, organic micromolecule, glutamic acid and nucleotide which belong to free polymers. Nutrient of oral liquid extracted from Sichuan ' Wenzhai Xuan ' 2014.3.7(14 th edition) ' health column
3. Each traditional Chinese medicine has the characteristics of multiple components, multiple targets and multiple effects, the effects of different parts of the same plant and the same animal are different, the contained components are different in the same plant and the same animal, and the common and individual characteristics of the traditional Chinese medicines are also different in the same plant and the same animal. The predecessors of China had a antithetical cloud: the tangerine peel, tangerine seed and tangerine pith have different fruit functions, and the common root effects of the perilla leaves, the perilla stems and the perilla seeds are different. "to this end, the formulations are different and the effect achieved by the light and heavy use of the amounts in particular is also different.
4. The water pill has the advantages that: convenient taking, only drinking water is needed, convenient carrying, reliable curative effect, no toxic side effect, resource saving and the like, and belongs to a green natural medicinal preparation.
Example 1
A person in a certain forest, male, 75 years old, is diagnosed with a pen in 2014, 4 months and 15 days, suffers from upper respiratory tract infection, suffers from anorexia caused by continuous use of antibiotics in a hospital, has a language like humming, is mentally unavailable, is diagnosed with the person in a convalescent by advanced medical care personnel, and is advised to stop fluid infusion and all antibiotic treatment, and only needs to drink Chinese medicine decoction. The 17-day incoming telegram in the same month of the year is greatly improved and is changed into the magnolia flower.
Example 2
When one of the ju and the woman is in 30 years and 18 years old, the patient suffers from the joint pain of the whole body and is not cured, the patient is asked for treatment without any effect by each party, the patient is diagnosed on the pen within 5 months and 22 days in 2015, one dose takes effect, and three doses cure.
Example 3
When a certain plum is a woman in age of 30 years and has a frigid nature, the woman can be diagnosed in 2013 in 11-16 months, the woman does not want to be contacted with the old and the father, the whole body is cold after the contact, particularly the plum is severe, especially if the plum enters the Guangdong cold palace, the frozen plum is trembled, the bear needs to be baked with big fire to warm the body and then the body is well caught (the plum is also true in summer), the plum is painful in all parts, and the plum is disgruntled like autumn cicadas and nearly separated from married hands, and the plum is prepared into water-bindered pills by the above components to be cured.
Example 4
When a certain patient is applied to a certain patient, the patient is a female in the age of 80, has pulmonary emphysema on both lungs and has changed pulmonary fibrosis, and the patient is diagnosed in 2014 and 23 days, so that the improvement is greatly improved.
Example 5
One Li in western city region of Pengshan county, Sichuan, is male, 76 years old, suffers from chronic bronchitis, emphysema and pulmonary obstruction for decades, is firstly diagnosed in Qingjiang town of Jintang county before spring in 1989, is diagnosed in Wuli dun of Chengdu city in 2003, and is diagnosed in Wuli dun of Chengdu city in three diagnoses, and the original Wuli dun is searched for help, and the person who says pen is not dry and returns home to nourish the old. In 2015, day 5 and day 18, the patient arrived in Qingjiang town of Jintang county, and then returned to home in 17 days for annual review of the care expense, and on the way to return to Chengdu, the patient received the phone in son-in-law, so that he had asked the phone in two women-in-law, and sent from two women-in-law to visit twelve bridge circuits 30 Yanghu & Tang famous physicians in the same year, day 19 in the same month, and then the patient was so rolled over to track why? The answer is to ask for the curative effect! Seek for rehabilitation! The traditional Chinese medicine is used as a water-mixing pill once the pill is opened for one year, and the pill is cured by adding gecko in 'jin Kui Shen Qi' and 'san Zi YangQin Tang' after the spring return diagnosis in 2016.
Example 6
A certain woman in age 55 is identified as late esophageal cancer at the upper section of the esophagus by gastroscope in provincial hospital in 15 days 5 and 15 days 2002, and the woman agrees to chemotherapy after surgery in a second national hospital in Nejiang province in 27 days in the same month in the same year, and goes home to be treated symptomatically by traditional Chinese medicines.
Example 7
Certain forest, male, 37 years old, Sichuan province people hospital immunoassay report shows that the tumor marker is a systemic tumor marker, and the medical record number is: 1207577, accession number: 510032, specimen number: number Z2013121277. The result was 1331.55ng/ml alpha fetoprotein, reference range 8.78. After one month, the pill is prepared by the inventor, the alpha fetoprotein is 16.17ng/ml, the pill is healed after three months, and a single inspection result report is attached.
Example 8
Discharge of the second school of western China of Sichuan university, namely Dang, a woman in 18 years old, proves that 7-month and 7-day admission in 2008 and No. 268211 in admission are carried out, and the patient is 7-year after operation because of 7-year dysmenorrhea, and the accessory occupation is found by the B-ultrasonic, and the removal of the whole-anesthesia descending double ovarian cyst is carried out on 7-month and 9-day in 2008, the right ovary of the patient contains chocolate-like viscous liquid, and the right ovary of the patient has 5+ cm cyst, and the patient is still painful and has white paper surface and impatience to aggravation after the operation to the menstrual period, so that medical experts in hospitals at all levels in adult cities seek treatment, and no effect can be seen. Doctor guidance in 2014, 12 and 19 days: "can find out the treatment of the doctor", the treatment takes effect once and does not change other people to treat, show in 2015 3, 2 days through Sichuan province medical science institute instrument Dc-8 ultrasonic No. 1503024375, uterus double attachments have not seen obvious abnormal sound image, this sick body is improved greatly, the red light is full of face, give off youthful breath, the energy of youth is overflowed to the ocean. Bian 14 years old, saying dysmenorrhea, tells the sound of vibration and surging.
Example 9
Some one, male and two years old, will be treated on the spot of the doctor's doctor with his milk, and the infant will have anorexia, cough and pharyngitis, and its finger print, white color, white and thick tongue coating, and the "Ginseng radix, radix bupleuri and Ershui, will be added to order his milk to be decocted for more than two hours for the first time. The grandparents of milk are Chinese medicine families, ask me for Chinese, do you use monkshood in summer-heat and summer? Is on the way of eating a bar at ease! The effect is good after taking. The treatment is confirmed from then on, and the patients are treated with improper diet or repeated treatment after taking western medicines. The doctor is also appointed to visit 3 and 13 months in 2017, and the doctor is treated along with the grandmother's milk.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (5)
1. The pill for preventing internal healthy qi and pathogenic factors from drying is characterized by comprising the following components: radix Glycyrrhizae Preparata (radix Glycyrrhizae Preparata) two, rhizoma Zingiberis (rhizoma Zingiberis recens) two halves, and radix Aconiti lateralis Preparata (radix Aconiti lateralis Preparata) 45g or two, radix Ginseng Rubra (radix Ginseng Rubra) two, radix bupleuri (radix bupleuri) two, ramulus Cinnamomi (ramulus Cinnamomi) two, Poria (Poria cocos) two, and rhizoma Atractylodis (rhizoma Atractylodis) two halves; the radix Aconiti lateralis is salted radix Aconiti lateralis.
2. The method for preparing the pill for treating internal healthy qi and pathogenic factors dryness according to claim 1, which comprises the following steps: mixing and drying honey-fried licorice root, dried ginger, monkshood, red ginseng, radix bupleuri, cassia twig, poria cocos and rhizoma atractylodis, cooling, carrying out coarse screening and crushing, repeatedly and uniformly mixing again after the secondary crushing, repeatedly carrying out fine screening and crushing, uniformly mixing with 2-3% of wheat flour paste, kneading into a material before bread steaming, and making into pills by a water pill machine.
3. The method of claim 2, wherein the monkshood is sterilized at a high temperature, cooled, and mixed with the honey-fried licorice root, the dried ginger, the red ginseng, the bupleurum root, the cassia twig, the poria cocos, and the atractylodes rhizome.
4. The preparation method according to claim 2, wherein the final product is dried to sterilize and dry, and the dried product is further processed according to the required temperature of the medicine, bottled and packaged, and finally sterilized by radiation.
5. The method of manufacturing according to claim 2, further comprising: the required authentic Chinese medicinal materials are refined according to the formula, and the Chinese medicinal materials are not mildewed, have no impurities, are not damaged by worms, have no pesticide residues, have no pollution of heavy metals and the like.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210491479.8A CN114796434A (en) | 2017-05-25 | 2017-05-25 | Pill for keeping healthy qi and pathogenic factors dry |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210491479.8A CN114796434A (en) | 2017-05-25 | 2017-05-25 | Pill for keeping healthy qi and pathogenic factors dry |
| CN201710412581.3A CN107213439A (en) | 2017-05-25 | 2017-05-25 | Neizhengbubugan pills |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710412581.3A Division CN107213439A (en) | 2017-05-25 | 2017-05-25 | Neizhengbubugan pills |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114796434A true CN114796434A (en) | 2022-07-29 |
Family
ID=59947269
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710412581.3A Pending CN107213439A (en) | 2017-05-25 | 2017-05-25 | Neizhengbubugan pills |
| CN202210491479.8A Pending CN114796434A (en) | 2017-05-25 | 2017-05-25 | Pill for keeping healthy qi and pathogenic factors dry |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710412581.3A Pending CN107213439A (en) | 2017-05-25 | 2017-05-25 | Neizhengbubugan pills |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN107213439A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114681582A (en) * | 2022-02-28 | 2022-07-01 | 刘若雨 | Oral traditional Chinese medicine composition for treating cold, preparation method and traditional Chinese medicine preparation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897940A (en) * | 2009-05-27 | 2010-12-01 | 煤炭总医院 | A kind of anti-fatigue traditional Chinese medicine formula and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552851B (en) * | 2012-02-03 | 2013-10-16 | 河南中医学院 | Traditional Chinese medicine for treating chronic gastrointestinal diseases |
| CN102698222A (en) * | 2012-05-18 | 2012-10-03 | 廖天源 | Drug for treating bradycardia and preparation method of drug |
-
2017
- 2017-05-25 CN CN201710412581.3A patent/CN107213439A/en active Pending
- 2017-05-25 CN CN202210491479.8A patent/CN114796434A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897940A (en) * | 2009-05-27 | 2010-12-01 | 煤炭总医院 | A kind of anti-fatigue traditional Chinese medicine formula and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 符健 等: "王国华应用四逆汤临床经验" * |
| 罗文明: "少阴病寒化证医案五则" * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107213439A (en) | 2017-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103977368A (en) | Traditional Chinese medicinal composition for treating arthralgia caused by rheumatic chills and fever and preparation method thereof | |
| CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
| CN108210657A (en) | A traditional Chinese medicine composition for preventing and treating lung cancer | |
| CN102430018B (en) | Medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN113209194B (en) | Composition for treating chronic gastritis and preparation method and application thereof | |
| CN114796434A (en) | Pill for keeping healthy qi and pathogenic factors dry | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
| CN106620133A (en) | Medicinal liquor having functions of invigorating the kidney, strengthening Yang and expelling wind-damp and preparation method thereof | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN105194207A (en) | Traditional Chinese medicine composition and application thereof | |
| CN116350731B (en) | Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof | |
| CN118304369B (en) | A traditional Chinese medicine composition for treating phlegm-dampness obstruction type hyperuricemia | |
| CN104435798A (en) | Traditional Chinese medicine preparation for improving neurasthenia and preparation method thereof | |
| CN103816450B (en) | A kind of Chinese medicine for the treatment of rheumatoid arthritis | |
| CN102631648A (en) | Chinese patent medicine for treating acute urticaria | |
| CN109316594B (en) | Decoction of Ershu dendrobe | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN105311613A (en) | Traditional Chinese medicine oral solution for treating chronic gastritis and preparation method | |
| CN105582379A (en) | Traditional Chinese medicine composition for treating liver-stomach disharmony and preparation method of traditional Chinese medicine composition | |
| CN105106842A (en) | Medicine for treating chronic hepatitis B | |
| CN104689205A (en) | Traditional Chinese preparation for treating insomnia and dreamful sleep and preparation method thereof | |
| CN103768251B (en) | A kind of medicine killed virus in blood cell, improve human antibody's immunizing power | |
| CN104435883A (en) | Traditional Chinese medicine preparation for treating calcaneodynia | |
| CN104474157A (en) | Traditional Chinese medicine for treating painful heel caused by phlegm-accumulation stasis | |
| CN110893230A (en) | Traditional Chinese medicine composition for improving immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |